Five cases of encephalitis during treatment of loiasis with diethylcarbamazine

Am J Trop Med Hyg. 1991 Jun;44(6):684-90. doi: 10.4269/ajtmh.1991.44.684.

Abstract

Five cases of encephalitis following treatment with diethylcarbamazine (DEC) were observed in Congolese patients with Loa loa filariasis. Two cases had a fatal outcome and one resulted in severe sequelae. The notable fact was that this complication occurred in three patients hospitalized before treatment began, with whom particularly strict therapeutic precautions were taken, i.e., initial dose less than 10 mg of DEC, very gradual dose increases, and associated anti-allergic treatment. This type of drug-induced complication may not be that uncommon in highly endemic regions. It occurs primarily, but not exclusively, in subjects presenting with a high microfilarial load. The relationship between the occurrence of encephalitis and the decrease in microfilaremia is evident. The pathophysiological mechanisms are discussed in the light of these observations and the few other comments on this subject published in the literature.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Diethylcarbamazine / administration & dosage
  • Diethylcarbamazine / adverse effects*
  • Diethylcarbamazine / therapeutic use
  • Encephalitis / chemically induced*
  • Female
  • Humans
  • Loiasis / drug therapy*
  • Male

Substances

  • Diethylcarbamazine